Metagen Therapeutics

Tsuruoka, Yamagata, Japan, 997-0000

https://www.metagentx.com/

Company profile

Metagen Therapeutics company profile

Metagen Therapeutics is a drug discovery and medical business company which utilizes microbiome science. The company promotes drug discovery and medical business using microbiome science. Metagen Therapeutics is a joint venture between Fast Track Initiative Co., Ltd. and Keio Innovation Co., Ltd.

Business identity

Website: https://www.metagentx.com/
Contact email: [email protected]
Operating status: Active
Company type: For Profit
Employee range: 1-10 employees
Revenue range: $0-$1M
Founded: 2020-01-17

LinkedIn Facebook X

Headquarters

Headquarters: Tsuruoka, Yamagata, Japan
Postal code: 997-0000
Country code: JP
Continent: Asia

Capital profile

Funding and company signals

Funding stage: Early Stage Venture
Funding rounds: 5
Total equity funding: $30.1M
Last funding: Series B / $15.7M / 2025-09-08
Last equity funding: Series B / $15.7M
Investors: 12
Lead investors: 2
Founders: 4
Articles: 3

Categories and groups

Biotechnology Clinical Trials Medical Therapeutics Biotechnology Health Care Science and Engineering

Founders and investors

Founders

Dai IshikawaShinji FukudaTakuji YamadaTaku Nakahara

Lead investors

Fast Track Initiative, Inc.JAFCO

Investors

Dentsu VenturesJIC Venture Growth InvestmentsKeio Innovation InitiativeMizuho CapitalSMBC Venture Capital